Kimberly Aardalen

Senior Director, Pre-clinical Pharmacology @ Odyssey Therapeutics

About

With over fifteen years of experience in the research and development of novel therapeutics in both the biotechnology and pharmaceutical industries, I have a demonstrated proficiency in in vivo and in vitro evaluation of novel drug candidates. I am a motivated and independent researcher who constantly seeks new scientific challenges in my work. My broad scientific background and passion for research, coupled with my extensive skill set provides me with a unique combination of qualifications and experience. In addition, I am a productive and collaborative team player with a commitment to the highest level of professional and personal excellence.

Country

United States

City

Boston

Industry

Biotechnology

Skill

Biomarkers, Lifesciences, Assay Development, Oncology, Drug Discovery, Drug Development, Biotechnology, Molecular Biology, Antibodies, Bioinformatics, Cell Culture, In Vitro, Life Sciences, Mouse Models

Experience

Senior Director, Pre-clinical Pharmacology

Odyssey Therapeutics

2025-1 - Present · 1 yr 9 mos

United States

Research Specialist I to Scientific Technical Leader I

Novartis

2001-1 - 2025-8 · 24 yrs 8 mos

Cambridge, Massachusetts

Scientific Technical Leader I 2014-Present Scientist II, Pharmacology 2011 –2014 Scientist I, Pharmacology 2008 – 2011 Scientific Associate II/ Research Specialist II, Pharmacology 2004 – 2008 Research Specialist I, Pharmacology 2001 – 2004 Designed, performed, and analyzed in vivo and in vitro studies to evaluate efficacy and PK/PD studies to support and progress multiple oncology pre-clinical programs. .

Associate Scientist III

XOMA US, LLC

1995-7 - 2001-1 · 5 yrs 7 mos

Berkeley, California

Associate Scientist IIl Pharmacology/Toxicology 1999 – 2001 Associate Scientist II Pharmacology/Toxicology 1995 – 1998 Provided pharmacology support in the development of recombinant-protein, peptide, immunofusion, and monoclonal antibody products. Therapeutic areas targeted bacterial or fungal infection, cardiovascular, and autoimmune diseases.